KOD
Price
$4.49
Change
+$0.05 (+1.13%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
234.27M
39 days until earnings call
VRCA
Price
$0.86
Change
+$0.04 (+4.88%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
75.75M
32 days until earnings call
Interact to see
Advertisement

KOD vs VRCA

Header iconKOD vs VRCA Comparison
Open Charts KOD vs VRCABanner chart's image
Kodiak Sciences
Price$4.49
Change+$0.05 (+1.13%)
Volume$3.63K
Capitalization234.27M
Verrica Pharmaceuticals
Price$0.86
Change+$0.04 (+4.88%)
Volume$10.93K
Capitalization75.75M
KOD vs VRCA Comparison Chart in %
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KOD vs. VRCA commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a StrongBuy and VRCA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (KOD: $4.44 vs. VRCA: $0.82)
Brand notoriety: KOD and VRCA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 133% vs. VRCA: 286%
Market capitalization -- KOD: $234.27M vs. VRCA: $75.75M
KOD [@Biotechnology] is valued at $234.27M. VRCA’s [@Biotechnology] market capitalization is $75.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileVRCA’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • VRCA’s FA Score: 0 green, 5 red.
According to our system of comparison, KOD is a better buy in the long-term than VRCA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 4 TA indicator(s) are bullish while VRCA’s TA Score has 5 bullish TA indicator(s).

  • KOD’s TA Score: 4 bullish, 5 bearish.
  • VRCA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VRCA is a better buy in the short-term than KOD.

Price Growth

KOD (@Biotechnology) experienced а +15.93% price change this week, while VRCA (@Biotechnology) price change was +26.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

KOD is expected to report earnings on Nov 12, 2025.

VRCA is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($234M) has a higher market cap than VRCA($75.8M). VRCA YTD gains are higher at: 24.643 vs. KOD (-54.874). VRCA has higher annual earnings (EBITDA): -55.56M vs. KOD (-162.44M). KOD has more cash in the bank: 139M vs. VRCA (29.6M). VRCA has less debt than KOD: VRCA (42.4M) vs KOD (67.6M). VRCA has higher revenues than KOD: VRCA (7.18M) vs KOD (0).
KODVRCAKOD / VRCA
Capitalization234M75.8M309%
EBITDA-162.44M-55.56M292%
Gain YTD-54.87424.643-223%
P/E RatioN/AN/A-
Revenue07.18M-
Total Cash139M29.6M470%
Total Debt67.6M42.4M159%
FUNDAMENTALS RATINGS
KOD vs VRCA: Fundamental Ratings
KOD
VRCA
OUTLOOK RATING
1..100
248
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4738
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KOD's Valuation (28) in the Biotechnology industry is significantly better than the same rating for VRCA (95) in the Pharmaceuticals Major industry. This means that KOD’s stock grew significantly faster than VRCA’s over the last 12 months.

KOD's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that KOD’s stock grew similarly to VRCA’s over the last 12 months.

KOD's SMR Rating (98) in the Biotechnology industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that KOD’s stock grew similarly to VRCA’s over the last 12 months.

VRCA's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as KOD (47) in the Biotechnology industry. This means that VRCA’s stock grew similarly to KOD’s over the last 12 months.

VRCA's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as KOD (100) in the Biotechnology industry. This means that VRCA’s stock grew similarly to KOD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KODVRCA
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 23 days ago
89%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
KOD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FNMAJ12.950.29
+2.33%
Fannie Mae
GRGTF2.68N/A
N/A
Grainger PLC
AUUMF14.25N/A
N/A
Aumann AG
CCHBF53.29N/A
N/A
COCA COLA HBC LTD
MOAEF0.07N/A
N/A
Mongolia Energy Corp., Ltd.

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with XNCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+1.13%
XNCR - KOD
56%
Loosely correlated
-0.54%
NRIX - KOD
49%
Loosely correlated
-3.87%
BEAM - KOD
48%
Loosely correlated
+2.66%
IMNM - KOD
47%
Loosely correlated
+0.67%
IDYA - KOD
46%
Loosely correlated
-0.74%
More

VRCA and

Correlation & Price change

A.I.dvisor tells us that VRCA and PBYI have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VRCA and PBYI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRCA
1D Price
Change %
VRCA100%
+6.53%
PBYI - VRCA
32%
Poorly correlated
-2.22%
ACOG - VRCA
30%
Poorly correlated
+1.85%
SLNO - VRCA
29%
Poorly correlated
-9.23%
FGEN - VRCA
29%
Poorly correlated
+18.74%
QURE - VRCA
27%
Poorly correlated
+0.07%
More